BioXcel Therapeutics (BTAI) Restructuring Costs (2023 - 2025)
Historic Restructuring Costs for BioXcel Therapeutics (BTAI) over the last 3 years, with Q3 2025 value amounting to $194000.0.
- BioXcel Therapeutics' Restructuring Costs fell 8750.8% to $194000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 7291.54%. This contributed to the annual value of $2.4 million for FY2024, which is 4136.44% down from last year.
- According to the latest figures from Q3 2025, BioXcel Therapeutics' Restructuring Costs is $194000.0, which was down 8750.8% from $33000.0 recorded in Q4 2024.
- Over the past 5 years, BioXcel Therapeutics' Restructuring Costs peaked at $4.2 million during Q3 2023, and registered a low of $33000.0 during Q4 2024.
- Over the past 3 years, BioXcel Therapeutics' median Restructuring Costs value was $856000.0 (recorded in 2024), while the average stood at $1.4 million.
- As far as peak fluctuations go, BioXcel Therapeutics' Restructuring Costs crashed by 6269.52% in 2024, and later plummeted by 8750.8% in 2025.
- Over the past 3 years, BioXcel Therapeutics' Restructuring Costs (Quarter) stood at $4.2 million in 2023, then plummeted by 99.21% to $33000.0 in 2024, then soared by 487.88% to $194000.0 in 2025.
- Its last three reported values are $194000.0 in Q3 2025, $33000.0 for Q4 2024, and $1.6 million during Q3 2024.